• Health & Medicine

New treatment for rare blood cancer approved for NHS use in England

The National Institute for Health and Care Excellence (NICE) has approved the drug brentuximab vedotin on the NHS in England. The National Institute for Health and Care Excellence (NICE) has approved the drug brentuximab vedotin on the NHS in England.

10 July 2020

• Health & Medicine
• Policy & Insight

Urgent cancer referrals being turned down during coronavirus pandemic 

Around a quarter of GPs have said that urgent referrals for suspected cancer had been turned down by hospitals more often than before the pandemic. Around a quarter of GPs have said that urgent referrals for suspected cancer had been turned down by hospitals more often than before the pandemic.

8 July 2020

• Science & Technology

Secrets of naked mole-rat cancer resistance unearthed

Naked mole-rats' exceptional resistance to cancer is thanks to unique conditions in their bodies that stop cancer cells multiplying, according to new research. Naked mole-rats' exceptional resistance to cancer is thanks to unique conditions in their bodies that stop cancer cells multiplying, according to new research.

1 July 2020

• Health & Medicine

Scotland's lifeline cancer trials must be restarted urgently

Cancer Research UK’s calls backed by eminent Edinburgh scientist who says the COVID-19 halt to clinical trials has taken away hope for some patients. Cancer Research UK’s calls backed by eminent Edinburgh scientist who says the COVID-19 halt to clinical trials has taken away hope for some patients.

29 June 2020

• Health & Medicine

Prostate cancer hormone therapy not recommended for NHS in England

A hormone therapy has been rejected for some adults with newly-diagnosed, advanced prostate cancer. A hormone therapy has been rejected for some adults with newly-diagnosed, advanced prostate cancer.

26 June 2020

• Health & Medicine

Targeted drug improves survival for children with non-Hodgkin lymphoma

New clinical trial results show that adding rituximab to standard chemotherapy could improve survival for some children with non-Hodgkin lymphoma. New clinical trial results show that adding rituximab to standard chemotherapy could improve survival for some children with non-Hodgkin lymphoma.

25 June 2020

• Charity News

£150 million per year could be cut from cancer research, warns charity

Cancer Research UK could be forced to cut £150 million per year from its research funding as the COVID-19 pandemic decimates its income. Cancer Research UK could be forced to cut £150 million per year from its research funding as the COVID-19 pandemic decimates its income.

24 June 2020

• Science & Technology

New blood test to monitor cancer up to ten times more sensitive than current methods

A new method of analysing cancer patients’ blood for evidence of the disease could be up to ten times more sensitive than previous methods. A new method of analysing cancer patients’ blood for evidence of the disease could be up to ten times more sensitive than previous methods.

17 June 2020

• For Supporters

Cancer Research UK stores to reopen from 29 June  

Cancer Research UK’s charity shops will start to reopen to the public from 29 June in England, and 6 July in Northern Ireland. Cancer Research UK’s charity shops will start to reopen to the public from 29 June in England, and 6 July in Northern Ireland.

17 June 2020

• Health & Medicine

Immunotherapy treatment recommended for advanced small cell lung cancer 

A new immunotherapy treatment has been recommended by the National Institute for Health and Care Excellence (NICE) for some adults with small cell lung cancer. A new immunotherapy treatment has been recommended by the National Institute for Health and Care Excellence (NICE) for some adults with small cell lung cancer.

5 June 2020

Race for Life events cancelled due to COVID-19

Cancer Research UK today announced that it has made the difficult decision to cancel Race for Life events across the UK this year as a result of COVID-19. Cancer Research UK today announced that it has made the difficult decision to cancel Race for Life events across the UK this year as a result of COVID-19.

4 June 2020

• Health & Medicine

Over 2 million people in backlog for cancer care

Around 2.4 million people in the UK are waiting for cancer screening, further tests or cancer treatment according to a new analysis by Cancer Research UK. Around 2.4 million people in the UK are waiting for cancer screening, further tests or cancer treatment according to a new analysis by Cancer Research UK.

1 June 2020